Australia's largest stock trading and investment forum Australia's #1 stock forum

OPT

Click for more information

1.65%

89.5¢ opthea limited

Analyst Upgrade, page-63

First 63 Last

Share
Profile

Follow
Jordan69

65 Posts.

5

04/02/21

13:27

Post #: 50706309
Share

Originally posted by mondy85: ↑

Aside from announcing the commencement of ph3 I’m not sure what else there is to say. Website states it will begin in the first half of 2021 and with old mate Covid refusing to leave the party just yet, this could be a few months away still. Plus, everyone knows ph3 is going to happen, so announcing it isn’t going to necessarily drive any meaningful SP movement (unless people are selling because they think OPT has secretly abandoned these trials and neglected to update the market!). As the website notes:

“The primary endpoint of both trials will be the mean change in visual acuity from baseline at week 52. Patients will continue to be dosed until week 96 to further assess long-term safety at week 100.”

Week 100........ long way to go. If you believe in the company and it’s management, this is a set-and-forget cake.

Expand

Thanks for your reply
I guess an update on how the recruitment for the trial going , when are we expecting to start dosing the patients , any new presentations / conferences , any commercial negotiations , basically anything to make us feel this stock has not been forgotten

I understand this is not a quick profit stock and we need a good 2-3 years before we see great returns , but some upward movement will be nice

OPT Price at posting: $1.83 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

What's causing the cost-of-living crisis, and how to navigate it

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

There are more pages in this discussion • 26 more messages in this thread...

First 63 Last

Add OPT (ASX) to my watchlist

(20min delay)
Last 89.5¢		Change -0.015(1.65%)		Mkt cap ! $1.101B

Open	High	Low	Value	Volume
91.0¢	92.0¢	87.5¢	$1.496M	1.676M

Buyers (Bids)

No.	Vol.	Price($)
1	1705	89.5¢

Sellers (Offers)

Price($)	Vol.	No.
90.5¢	46363	2

View Market Depth

No.	Vol.	Price($)
3	35003	0.875
6	48503	0.870
2	12500	0.865
3	29213	0.860
1	1167	0.855

Price($)	Vol.	No.
0.905	30001	1
0.910	45000	1
0.915	10200	1
0.920	543	1
0.925	639	1

Last trade - 16.10pm 18/10/2024 (20 minute delay)

OPT (ASX) Chart